EurekaMag.com logo
+ Site Statistics
References:
53,214,146
Abstracts:
29,074,682
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

RT-PCR for tyrosinase expression as a molecular marker in malignant melanoma


Journal of B.U.On. 7(4): 325-330
RT-PCR for tyrosinase expression as a molecular marker in malignant melanoma
As the incidence of malignant melanoma steadily increases the need for markers in detection of early metastasis and guidance of therapy has become urgent. Presence of melanoma cells in patient peripheral blood, lymph nodes or bone marrow (BM) specimens could indicate tumour dissemination, and thus a high risk of metastasis. In 1991 coupled Reverse Transcription and Polymerase Chain Reaction (RT-PCR) was firstly used to detect tyrosinase mRNA in the peripheral blood of melanoma patients. Since then numerous studies have evaluated the significance of tyrosinase expression in bone marrow specimens, lymph nodes and blood from melanoma patients and there results indicate that this method might have important clinical applications in melanoma management.

(PDF 0-2 workdays service: $29.90)

Accession: 055338862

PMID: 17955575



Related references

Tyrosinase expression as a molecular marker for investigating the presence of circulating tumor cells in melanoma patients. Current Cancer Drug Targets 10(5): 529-538, 2010

Incomplete expression of the tyrosinase gene family (Tyrosinase, TRP-1, and TRP-2) in human malignant melanoma cells in vitro. Pigment Cell Research 8(6): 307-313, 1995

Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors. Archives of Pathology & Laboratory Medicine 127(9): 1083-4; Author Reply 1084-5, 2003

Tyrosinase expression in malignant melanoma, desmoplastic melanoma, and peripheral nerve tumors: An immunohistochemical study. Archives of Pathology & Laboratory Medicine 126(7): 816-822, July, 2002

Tyrosinase and MUC18 expression in the peripheral blood as a tumor marker for melanoma. Proceedings of the American Association for Cancer Research Annual Meeting 39: 202, March, 1998

Tyrosinase activity in three types of the malignant melanoma: superficial spreading melanoma, lentigo maligna melanoma and nodular melanoma. Archiv für Dermatologische Forschung 252(3): 193-201, 1975

Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma. American Journal of Surgical Pathology 25(2): 197-204, 2001

Conversion of particulate tyrosinase to soluble form and to desialylated tyrosinase in human malignant melanoma. Febs Letters 80(1): 225-228, 1977

Desmoplastic malignant melanoma Expression of POMC derived antigens, tyrosinase, and DNA content. Modern Pathology 12(1): 56A, 1999

Expression of tyrosinase, MIA and MART-1 in sentinel lymph nodes of patients with malignant melanoma. British Journal of Dermatology 146(2): 244-249, February, 2002